» Articles » PMID: 21188243

Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic Diagnosis

Overview
Date 2010 Dec 29
PMID 21188243
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Accumulating evidence indicates that ATP-binding cassette (ABC) transporter ABCG2 plays a key role in regulating the cellular accumulation of porphyrin derivatives in cancer cells and thereby affects the efficacy of photodynamic therapy and photodynamic diagnosis. The activity of porphyrin efflux can be affected by genetic polymorphisms in the ABCG2 gene. On the other hand, Nrf2, an NF-E2-related transcription factor, has been shown to be involved in oxidative stress-mediated induction of the ABCG2 gene. Since patients have demonstrated individual differences in their response to photodynamic therapy, transcriptional activation and/or genetic polymorphisms of the ABCG2 gene in cancer cells may affect patients' responses to photodynamic therapy. Protein kinase inhibitors, including imatinib mesylate and gefitinib, are suggested to potentially enhance the efficacy of photodynamic therapy by blocking ABCG2-mediated porphyrin efflux from cancer cells. This review article provides an overview on the role of human ABC transporter ABCG2 in photodynamic therapy and photodynamic diagnosis.

Citing Articles

Characterization of resistant MCF-7 breast cancer cells developed by repeated cycles of photodynamic therapy.

Aniogo E, George B, Abrahamse H Front Pharmacol. 2022; 13:964141.

PMID: 36188530 PMC: 9523167. DOI: 10.3389/fphar.2022.964141.


Adipose-Derived Mesenchymal Stem Cells Responses to Different Doses of Gamma Radiation.

Taeb S, Mosleh-Shiraz M, Ghaderi A, Mortazavi S, Razmkhah M J Biomed Phys Eng. 2022; 12(1):35-42.

PMID: 35155291 PMC: 8819260. DOI: 10.31661/jbpe.v0i0.1212.


Multidrug efflux transporter ABCG2: expression and regulation.

Kukal S, Guin D, Rawat C, Bora S, Kumar Mishra M, Sharma P Cell Mol Life Sci. 2021; 78(21-22):6887-6939.

PMID: 34586444 PMC: 11072723. DOI: 10.1007/s00018-021-03901-y.


Key transporters leading to specific protoporphyrin IX accumulation in cancer cell following administration of aminolevulinic acid in photodynamic therapy/diagnosis.

Lai H, Nakayama T, Ogura S Int J Clin Oncol. 2020; 26(1):26-33.

PMID: 32875514 DOI: 10.1007/s10147-020-01766-y.


Establishment and characterization of human osteosarcoma cells resistant to pyropheophorbide-α methyl ester-mediated photodynamic therapy.

Tao Y, Ou Y, Yin H, Chen Y, Zhong S, Gao Y Int J Oncol. 2017; 51(5):1427-1438.

PMID: 29048645 PMC: 5642392. DOI: 10.3892/ijo.2017.4136.


References
1.
Bosch T, Kjellberg L, Bouwers A, Koeleman B, Schellens J, Beijnen J . Detection of single nucleotide polymorphisms in the ABCG2 gene in a Dutch population. Am J Pharmacogenomics. 2005; 5(2):123-31. DOI: 10.2165/00129785-200505020-00005. View

2.
Noble M, Endicott J, Johnson L . Protein kinase inhibitors: insights into drug design from structure. Science. 2004; 303(5665):1800-5. DOI: 10.1126/science.1095920. View

3.
Cullinan S, Diehl J . PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J Biol Chem. 2004; 279(19):20108-17. DOI: 10.1074/jbc.M314219200. View

4.
Gray M, Lipson R, MAECK J, Parker L, Romeyn D . Use of hematoporphyrin derivative in detection and management of cervical cancer. Am J Obstet Gynecol. 1967; 99(6):766-71. DOI: 10.1016/0002-9378(67)90392-4. View

5.
Nurse P . Nobel Lecture. Cyclin dependent kinases and cell cycle control. Biosci Rep. 2003; 22(5-6):487-99. DOI: 10.1023/a:1022017701871. View